Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Operating Activities

    Back to Cashflow Statement
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹-828 Cr₹-265 Cr₹625 Cr₹1,109 Cr₹1,131 Cr

What is the latest Cash Flow from Operating Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Operating Activities ratio of GLENMARK PHARMACEUTICALS is ₹-828 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹-828 Cr
Mar2024₹-265 Cr
Mar2023₹625 Cr
Mar2022₹1,109 Cr
Mar2021₹1,131 Cr

How is Cash Flow from Operating Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹-828 Cr
Negative
Mar2024 ₹-265 Cr
Negative
Mar2023 ₹625 Cr
-43.59
Mar2022 ₹1,109 Cr
-1.99
Mar2021 ₹1,131 Cr -

Compare Cash Flow from Operating Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,212.0 Cr 3.5% 3% 40.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,050.0 Cr -0.9% -3.9% 1.3% Stock Analytics
DIVIS LABORATORIES ₹158,157.0 Cr -0.4% -7.6% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,531.0 Cr -2% -7.5% 27.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,190.0 Cr -1.5% -9.3% 3.8% Stock Analytics
CIPLA ₹98,892.8 Cr 1.7% -8.3% -16.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.5%

3%

40.1%

SENSEX

4.8%

-4.2%

0.8%


You may also like the below Video Courses